TL;DR
- Idea: Decentralized science platform integrating autonomous AI agents to democratize biotech research funding and development
- Catalyst: Recent V2 upgrade, Biofy product launch, strong trending and funding momentum
- Risks: High volatility, regulatory uncertainty in biotech tokenization, adoption risk for DeSci consumer platform
- Score: 7.00/ 10
Coin
- Name/ Ticker: Bio Protocol (BIO)
- Segment: DeSci
- Status: active
- Price: $0.044300
Key Metrics
- Market Cap: $86 554 694
- FDV: $151 040 000
- Circulating Supply: 1 769 745 956
- Total Supply: 3 320 000 000
Sources
Technology
- USP: First AI-driven DeSci platform enabling decentralized biotech research via autonomous BioAgents
- Core Technology: Autonomous on-chain AI agents (BioAgents), BioLaunchpad, decentralized governance via DAO, token-driven funding and IP tokenization across Ethereum, Base, and Solana
Roadmap
- 2025-01-03: Token Generation Event & Mainnet Launch on Ethereum and Solana
- 2025-04-02: V1 Upgrade with BioLaunchpad and AI-driven BioAgents integration
- 2025-08-03: V2 Phase Launch with linear token vesting and new features
- 2025-12-23: Biofy commerce layer launch bridging DeSci to consumer products
Team & Investors
Team
- Tokenomics Lead — Paul Kohlhaas: Former Founder at VitaDAO and bioeconomics strategist
- R&D & Community Lead — James Sinka: R&D specialist with community building experience in biotech and blockchain
- Product Head — Clemens Ortlepp: Led product development with expertise in AI and DeSci platforms
- Legal Counsel — Jose Pinto: Experienced crypto regulatory advisor based in Switzerland
- Growth Lead — Nate Hindman: Growth and marketing strategist with background in biotech funding
Investors
- Maelstrom Capital — Seed • 2025-09-17 • $6.90M
- Mechanism Capital — Seed • 2025-09-17
- Animoca Brands — Seed • 2025-09-17
- Zee Prime Capital — Seed • 2025-09-17
- Mirana Ventures — Seed • 2025-09-17
- Foresight Ventures — Seed • 2025-09-17
- Big Brain Holdings — Seed • 2025-09-17
- Panga Capital — Seed • 2025-09-17
Total funding: $6.90M
Tokenomics
- Utility: Governance, staking for BioAgents and participation in BioLaunchpad funding rounds
- Vesting: Linear vesting for 4.23% of tokens from Nov 2025 to May 2026
- Next Unlock: 2026-05-01 (4.23% of circulating)
Pros & Cons
Strengths
- Pioneering AI-driven decentralized science platform
- Strong institutional and foundation backing
- Multi-chain deployment on Ethereum, Base, and Solana
- Robust DAO governance and funding mechanisms
- Real-world product integration via Biofy commerce layer
Weaknesses
- High price volatility and downtrend of 93% since launch
- Regulatory uncertainty in tokenized biotech sector
- Adoption risk for novel consumer-facing Biofy platform
- Dependence on continuous funding and agent performance
- Limited liquidity compared to major DeFi tokens
Market Signals (7d)
- TVL trend: increasing
- CEX volume trend: stable
- Active addresses trend: increasing
Price Scenarios (target: 2026-07-03)
- Bear: $0.022150 — Assumes continuation of token depreciation trend observed since launch, resulting in 50% price drop by target date
- Base: $0.044300 — Assumes stabilization at current price level based on neutral market and protocol fundamentals
- Bull: $0.088600 — Assumes 100% price appreciation driven by widespread Biofy adoption and V2 ecosystem growth
How to Buy & Store
CEX
- Binance
- Coinbase
- Kraken
- OKX
- Deepcoin
- Gate.io
- MEXC
DEX
- Uniswap
- SushiSwap
- PancakeSwap
- Raydium
- BaseSwap
- 1inch
- Serum
Storage
- MetaMask
- Ledger Nano S
- Trust Wallet
- Coinbase Wallet
- Phantom
Verdict
Bio Protocol is a promising DeSci infrastructure play with unique AI-driven features and strong backing, but faces execution and adoption risks amid high volatility.
Official Links
Source: Coin Research (internal)
Comments (0)